However, the increased expression of YBX1 was associated with better overall survival in adrenocortical carcinoma, liver hepatocellular carcinoma, mesothelioma, and sarcoma patients (p < 0.05). This evidence concerns the gene YBX1 and adrenal cortex carcinoma.